N-terminal Pro-B-type natriuretic peptide and ventricular dysfunction in children and adolescents

Cardiology in the Young

Volumn 19, Issue 6, 2009, Pages 580-588

  Kocharian, Armen ^a   Shabanian, Reza ^a   Rahimzadeh, Mitra ^b   Kiani, Abdolrazagh ^a   Hosseini, Ahmad ^a   Zanjani, Keyhan Sayadpour ^a   Heidari Bateni, Giv ^a   Hosseini Navid, Nasrollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Biomarker; Diagnostic test; Diastolic dysfunction; Myocardial performance index

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; AORTA VALVE DISEASE; ARTICLE; CARDIOMYOPATHY; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT RIGHT SHUNT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN BLOOD LEVEL; PULMONARY VALVE STENOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION; THALASSEMIA;

ADOLESCENT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFANT; LINEAR MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION;

EID: 76349109479     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109991144     Document Type: Article

References (30)

1. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-2368.
2. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-654.
3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
4. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of Bnatriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
5. Scardovi AB, Coletta C, Aspromonte N, et al. Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure. Eur J Echocardiogr 2007; 8: 30-36.
6. Detaint D, Messika-Zeitoun D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005; 111: 2391-2397.
7. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 2005; 96: 1445-1448.
8. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol 2001; 37: 379-385.
9. Richards AM, Nicholls MG, Yandle TG, et al. Plasma Nterminal pro-brain natriuretic peptide and adrenomedullin. Circulation 1998; 99: 1921-1929.
10. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005; 11 (5 Suppl): S76-S80.
11. Hammerer-Lercher A, Geiger R, Mair J, et al. Utility of Nterminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients. Clin Chem 2006; 52: 1415-1419.
12. Nasser N, Bar-Oz B, Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 2005; 147: 248-253.
13. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644-648.
14. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-270.
15. O'Leary PW. Pediatric diastology: use and limitations of Doppler echocardiography in the evaluation of ventricular diastolic function in children. Prog Pediatr Cardiol 1999; 10: 83-93.
16. O'Leary PW, Durongpisitkul K, Cordes TM, et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998; 73: 616-628.
17. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366.
18. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-469.
19. Shimizu H, Masuta K, Aono K, et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002; 316: 129-135.
20. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-1574.
21. Kass DA. Assessment of diastolic dysfunction. Invasive modalities. Cardiol Clin 2000; 18: 571-586.
22. Grodecki PV, Klein AL. Pitfalls in the echo-Doppler assessment of diastolic dysfunction. Echocardiography 1993; 10: 213-234.
23. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJJT. Nterminal pro-B-type natriuretic peptide: plasma levels from birth to adolescence: elevated levels at birth and in heart diseases. Acta Paediatr 2004; 93: 603-607.
24. Rauh M, Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in control population of infants and children. Clin Chem 2003; 49: 1563-1564.
25. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003; 89: 875-878.
26. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
27. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004; 109: 3176-3181.
28. Williams RV, Ritter S, Tani LY, Pagoto LT, Minich LL. Quantitative assessment of ventricular function in children with single ventricles using the Doppler myocardial performance index. Am J Cardiol 2000; 86: 1106-1110.
29. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169-178.
30. Perlowski AA, Aboulhosn J, Castellon Y, Miner P, Child JS. Relation of brain natriuretic peptide to myocardial performance index in adults with congenital heart disease. Am J Cardiol 2007; 100: 110-114.